Solid lipid based nanocarriers: An overview / Nanonosači na bazi čvrstih lipida: Pregled

  • Pardeshi C
  • Rajput P
  • Belgamwar V
  • et al.
N/ACitations
Citations of this article
51Readers
Mendeley users who have this article in their library.

Abstract

In the era of nanoparticulate controlled and site specific drug delivery systems, use of solid lipids to produce first generation lipid nanoparticles, solid lipid nanoparticles (SLN), became a revolutionary approach in the early nineties. The present review is designed to provide an insight into how SLN are finding a niche as promising nanovectors and forms a sound basis to troubleshoot the existing problems associated with traditional systems. Herein, authors had tried to highlight the frontline aspects prominent to SLN. An updated list of lipids, advanced forms of SLN, methods of preparation, characterization parameters, and various routes of administration of SLN are explored in-depth. Stability, toxicity, stealthing, targeting efficiency and other prospectives of SLN are also discussed in detail. The present discussion embodies the potential of SLN, now being looked up by various research groups around the world for their utility in the core areas of pharmaceutical sciences, thereby urging pharmaceutical industries to foster their scale-up.

Cite

CITATION STYLE

APA

Pardeshi, C., Rajput, P., Belgamwar, V., Tekade, A., Patil, G., Chaudhary, K., & Sonje, A. (2013). Solid lipid based nanocarriers: An overview / Nanonosači na bazi čvrstih lipida: Pregled. Acta Pharmaceutica, 62(4), 433–472. https://doi.org/10.2478/v10007-012-0040-z

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free